NCT01686711View on ClinicalTrials.gov

A Double-blind, Parallel Group, Comparative Study of Coadministration AD-4833 and SYR-322

PHASE4CompletedINTERVENTIONAL
Enrollment

207

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Diabetes Mellitus
Interventions
DRUG

AD-4833 15 mg

DRUG

AD-4833 30 mg

DRUG

Placebo

Trial Locations (25)

Unknown

Hirosaki-shi

Kisaratsu-shi

Matsuyama

Fukuoka

Kitakyushu-shi

Kurume-shi

Fukuyama-shi

Hiroshima

Sapporo

Koga-shi

Yokohama

Kumamoto

Miyazaki

Suita-shi

Koshigaya-shi

Ōtsu

Chiyoda-ku

Chuo-ku

Itabashi-ku

Meguro-ku

Minato-ku

Ohta-ku

Shinjuku-ku

Toyama

Shimonoseki-shi

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY